About Gameto
Gameto is a Healthcare company based in United States founded in 2020 by Dina Radenkovic and Martin Varsavsky. It operates as a therapeutics for fertility and menopause treatments are developed. Gameto has raised $127 million across 5 funding rounds from investors including RA Capital, FJ Labs and Plum Alley Investments. Its chief executive is Dina Radenkovic. Gameto offers products and services including Fertilo. Its focus areas include Life Sciences, Women Health, Drugs and Reproductive Diseases. Its legal entity is GAMETO, INC. Its competitors include Sprout Pharmaceuticals, ObsEva, Hope Medicine, Rejoni and Naari and 3 more; 8 of its 8 listed competitors have raised funding.
Company details
Gameto was founded in 2020 in the United States as a biotechnology company. Therapeutics targeting fertility and menopause are developed to address womens health needs. Operations center on research and development of innovative treatments in these areas. The company is co-founded by Dina Radenkovic, who serves as CEO, and Martin Varsavsky. Focus remains on advancing solutions within the reproductive health sector.
- Headquarters United States
- Founders Dina Radenkovic, Martin Varsavsky
- SectorsHealthcare
- Website gametogen.com
- Social LinkedIn X
- Legal Name Gameto, Inc.
- Total Equity Funding$127M (USD)
in 5 rounds
- Latest Funding Round$44M (USD), Series C
Aug 2025
- InvestorsRA Capital
& 28 more
Products & Services of Gameto
Gameto offers a comprehensive portfolio of products and services, including Fertilo.
iPSC-based treatment to enhance IVF success and reduce hormone use
Funding Insights of Gameto
Gameto has successfully raised a total of $127M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $44 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $127M
- Total Rounds 5
- Last Round Series C — $44M
- First Round $3M
(Mar 2020)
- Investors Count 29
All 5 funding rounds of Gameto with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2025 | $44M | Series C | – | Overwater Ventures | |
| May 2024 | $43M | Series B | – | Two Sigma Ventures, RA Capital Management | |
| Sep 2022 | $17M | Series A | – | Insight Partners, Myelin | |
| Jan 2022 | $20M | Series A | – | Future Ventures | |
| Mar 2020 | $3M | Seed | – | – |
29 investors in total: 21 institutional and 8 angel.
Investors in Gameto
Gameto has secured backing from 29 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include RA Capital, FJ Labs and Plum Alley Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments in tech sectors are managed by the firm. | – | twosigmaventures.com | New York, United States | |
Investment firm scaling software and technology companies from early to late stages. | – | insightpartners.com | - | |
Future Ventures is focused on early-stage venture capital investments. | – | future.ventures | Los Altos, United States | |
Early-stage life sciences and tech focused VC firm investing primarily in the US | – | boldcapitalpartners.com | Santa Monica, United States | |
Ingeborg Investments is focused on funding women-led startups. | – | ingeborginvestments.com | - | |
- | – | amplifyherventures.com | - | |
Venture capital investments are provided to innovative founders. | – | myelin.vc | - | |
Early-stage technology startups are supported through venture capital investments. | – | taventures.vc | Frankfurt Am Main, Germany | |
Venture capital investing with a focus on diversity and inclusion in the ecosystem. | – | gaingels.com | - | |
Korify Capital is engaged in venture capital investments. | – | korifycapital.com | - |
Investor details for Gameto
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Gameto
31 people are tracked at Gameto (13 in leadership, 14 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Dina Radenkovic | Co-Founder & CEO | Leadership |
Martin Varsavsky | Co-Founder | Leadership |
Christian Kramme | Chief Scientific Officer | Leadership |
Isai Castaneda | VP of Finance & Accounting | Leadership |
Agustina Imfeld | Counsel & Chief Legal Officer | Leadership |
Carlos Lejtik | Medical Director | Leadership |
Gus Haddad | Chief Medical Officer | Leadership |
Emily Bosworth | Director Of Business Development & Corporate Strategy | Leadership |
Kylie Jordan | Director Of Investor Relations And Corporate Communications | Leadership |
Jean-Pierre Gotteland | Head of Development | Leadership |
Bruna Paulsen | VP of Manufacturing & Therapeutic Development | Leadership |
Tammie Roy | Clinical Director for Australia | Leadership |
Agustina Figueroa Imfeld | Chief Legal Officer | Leadership |
Philip Jordan | Scientific Advisor | Board & advisors |
Kristin Baldwin | Scientific Advisor | Board & advisors |
Dylan Morris | Director | Board & advisors |
Maryanna Saenko | Director | Board & advisors |
Mary Herbert | Scientific Advisor | Board & advisors |
Matthew Vermilyea | Scientific Advisor | Board & advisors |
Peter Klatsky | Scientific Advisor | Board & advisors |
11 more people are available in the full profile.
Complete people profiles for Gameto
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Gameto
3 dated milestones of Gameto across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Gameto is founded.
- Funding First funding round of $3.0M.
- Funding Latest funding round, Series C, of $44.0M.
Competitors of Gameto
Gameto has 8 listed competitors in our database, 8 of them funded. They include Sprout Pharmaceuticals, ObsEva, Hope Medicine, Rejoni and Naari, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sproutpharmaceuticals.com | 2011 | Raleigh, United States | $185.16M | 31 | Drugs for hypoactive sexual desire disorder in women are developed. | |
| obseva.com | 2012 | Geneva, Switzerland | $94.7M | – | Therapeutics for women's reproductive health and pregnancy are developed. | |
| hopemedinc.com | 2018 | Shanghai, China | $56M | – | Monoclonal antibodies are developed for treating multiple diseases. | |
| rejoni.com | 2020 | Bedford, United States | $41.25M | – | Therapeutics for women's health conditions are developed using innovative hydrogels. | |
| naari.co | 2007 | Noida, India | $18.98M | 195 | Women care medicines are manufactured by Naari in India. | |
| forendo.com | 2013 | Turku, Finland | $25.58M | – | Small molecule therapeutics for reproductive health are developed. | |
| noratherapeutics.com | 2007 | Palo Alto, United States | $37.81M | – | Therapeutics for IVF failure and recurrent pregnancy loss are developed. | |
| preglem.com | 2006 | Geneva, Switzerland | $57.94M | – | Innovative drugs for women's reproductive medicine are developed and commercialized. |
Detailed competitors of Gameto
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Gameto
The website of Gameto (gametogen.com) receives about 5.5K visits a month.
- Monthly visits5.5K
▲ 24.5% vs previous month
Top companies in Women's Health & Fertility
10 companies that operate in the same segment as Gameto (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 861 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gameto
Complete news archive for Gameto
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gameto
Gameto was founded in 2020.
Gameto is headquartered in United States.
Dina Radenkovic is the current CEO of Gameto. They have also founded this company.
Gameto is a funded company, having raised a total of $127M across 5 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on Mar 2020.
Gameto was founded in 2020 in the United States as a biotechnology company. Therapeutics targeting fertility and menopause are developed to address womens health needs. Operations center on research and development of innovative treatments in these areas. The company is co-founded by Dina Radenkovic, who serves as CEO, and Martin Varsavsky. Focus remains on advancing solutions within the reproductive health sector.
Gameto's top competitors include Sprout Pharmaceuticals, Rejoni and Hope Medicine.
Gameto offers Fertilo.
Gameto has 29 investors. Key investors include RA Capital, FJ Labs, Plum Alley Investments, Two Sigma Ventures, and Insight Partners.
Gameto operates through Gameto, Inc..